APOA1 and Alzheimer disease: The inverse association of plasma apoA-I and HDL-cholesterol (HDL-C) levels with AD risk in some [5,6], but not all [7,8,9] epidemiological studies suggests that HDL may have functional properties that protect against AD that are not necessarily captured by measurement of apoA-I or HDL-C levels per se.